We don't formulate performance. We engineer it.
EVOQ engineers spherical metamaterials through a patented high-energy laser-ablation platform. Structure is controlled during formation—without chemical synthesis or post-synthetic correction—to create consistent materials ready for application development. EVQ-218, our most extensively studied silver metamaterial, is backed by peer-reviewed characterization and broad-spectrum antimicrobial research.
Structure engineered at production
Shape, size distribution, stability, and production consistency begin with how the material is made.
1. Shape
High-energy laser ablation produces highly spherical EVQ-218 material with a consistent, smooth morphology.
2. Size distribution
Peer-reviewed characterization reports a very narrow size distribution, providing a consistent starting material for application development.
3. Stability
EVQ-218 characterization reports stable, nonemissive surface behavior without added capping agents.
4. Production
Exceptional batch-to-batch consistency.
Built for repeatable material performance
EVOQ controls material structure during formation instead of relying on chemical reducing agents, surfactants, capping agents, or corrective post-processing. The result is a consistent material platform for defined formulations, substrates, and applications.
What the EVOQ platform enables
Precise particle structure
Spherical morphology and a very narrow size distribution are engineered at production, creating a consistent material platform for research and application development.
Surface behavior without coatings
EVQ-218 is produced without added capping agents, polymers, or surfactant coatings—so the material surface remains central to its behavior.
A platform for focused research
The platform is designed to support work across antimicrobial materials, device and coating concepts, and other high-value material applications.
Evidence ready for review
Peer-reviewed publications, third-party testing, and technical resources help teams evaluate the platform on its own merits.
Published research. Study-level results.
Start with peer-reviewed EVQ-218 characterization and serial-passage research, then explore antimicrobial, biocompatibility, coating, polymer, and device-format test records.
Explore the evidenceA platform built across material systems
EVOQ is developing its high-energy laser-ablation platform across multiple material systems. Each material is introduced with its own characterization, development status, and application evidence.
How the platform worksEVQ-218: the platform in practice
EVQ-218 has demonstrated broad-spectrum in vitro antimicrobial activity across more than 64 bacterial, fungal, and mycobacterial isolates. Published serial-passage research found no measurable increase in MIC after 30 passages across all six ESKAPE pathogens.
Review EVQ-218 resultsMedical-device and material development
Explore developmentTherapeutic research
Explore the researchEnergy materials
Read EVQ-GA researchHave a defined application in mind?
Tell us the material format, substrate, target endpoint, test method, and development stage. We’ll connect you with the most relevant evidence and evaluation pathway.
Ask an expert